TLDR Corexa Pharmacy topped $600,000 in July revenue with a $7 million run rate. DataMeds expands GLP-1 access through oral and injectable treatment options. Health Lives Here is set for a September public rollout starting in North Carolina. Corexa adds supplements and non-GLP-1 ...
DataMeds AI, Inc. (MEDS) Stock: Corexa Pharmacy Eyes Stronger H2 2026 Growth
其他语言标题
- 한국어DataMeds AI, Inc. (MEDS) 주식: Corexa 약국, 2026년 하반기 더 강한 성장 전망